help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2002-0379
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geserick, C.
Right arrow Articles by Haendler, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geserick, C.
Right arrow Articles by Haendler, B.
Molecular Endocrinology 17 (9): 1738-1750
Copyright © 2003 by The Endocrine Society

Differential Modulation of Androgen Receptor Action by Deoxyribonucleic Acid Response Elements

Christoph Geserick, Hellmuth-Alexander Meyer, Karina Barbulescu and Bernard Haendler

Research Laboratories of Schering AG, D-13342 Berlin, Germany

Address all correspondence and requests for reprints to: Dr. B. Haendler, Corporate Research Business Area Oncology, Schering AG, Müllerstrasse 178, D-13342 Berlin, Germany. E-mail: bernard.haendler{at}schering.de.

In addition to the steroid response elements (SREs), which are recognized by several steroid receptors, a second class of DNA elements exhibiting selectivity for the androgen receptor (AR) and named androgen response elements (AREs) has been identified. Here we provide evidence for the differential role of these element classes in modulating AR function. AR complexes attached to response elements representative of each class were purified. Limited protease digests of ARE- or SRE-bound AR complexes led to the generation of different patterns, in line with differential accessibilities. In transactivation assays, mutations in the AR dimerization interface of the DNA-binding domain had various effects, depending on the response elements tested. The R598D mutant displayed much enhanced activity on SREs, whereas far less effect was seen on the selective AREs. The A596T mutant had reduced activity on AREs but not on SREs. Ectopic expression of the coactivators transcriptional intermediary factor 2 (TIF2) and ARA55 stimulated AR activity to different extents, depending on the response element. When using cysteine-rich secretory protein 1 (CRISP-1) SRE as reference, the most significant difference was observed with Pem ARE-2. A differential response of each element class was furthermore observed in the presence of two enzymes involved in the sumoylation pathway. Ubiquitin-conjugating enzyme 9 (Ubc9) overexpression enhanced AR action conveyed by SREs, whereas little effect was seen on Pem ARE-1 and repression on Pem ARE-2. Protein inhibitor of activated STAT (PIAS)x{alpha} overexpression had little influence on SRE-mediated AR activity but was repressive when using AREs. Altogether, these results demonstrate that DNA response elements play an important modulatory role in transmitting AR action and may be determinative for specificity of gene expression in cell or tissue types.

NURSA Molecule Pages Link:

Nuclear Receptors:   GR  |  AR
Coregulators:   ARIP3  |  ARA55  |  UBC9  |  GRIP1
Ligands:   Dexamethasone  |  R1881



This article has been cited by other articles:


Home page
EndocrinologyHome page
I. N. Karatsoreos, A. Wang, J. Sasanian, and R. Silver
A Role for Androgens in Regulating Circadian Behavior and the Suprachiasmatic Nucleus
Endocrinology, November 1, 2007; 148(11): 5487 - 5495.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Lai, M.-A. Kedda, K. Hinze, R. L.G. Smith, J. Yaxley, A. B. Spurdle, C.P. Morris, J. Harris, and J. A. Clements
PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility
Carcinogenesis, May 1, 2007; 28(5): 1032 - 1039.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Z. Lu, S. E. Wardell, K. L. Burnstein, D. Defranco, P. J. Fuller, V. Giguere, R. B. Hochberg, L. McKay, J.-M. Renoir, N. L. Weigel, et al.
International Union of Pharmacology. LXV. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Glucocorticoid, Mineralocorticoid, Progesterone, and Androgen Receptors
Pharmacol. Rev., December 1, 2006; 58(4): 782 - 797.
[Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. A. MacLean II, M. K. Rao, K. M.H. Doyle, J. S. Richards, and M. F. Wilkinson
Regulation of the Rhox5 Homeobox Gene in Primary Granulosa Cells: Preovulatory Expression and Dependence on SP1/SP3 and GABP
Biol Reprod, December 1, 2005; 73(6): 1126 - 1134.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
J. Brodie and I. J McEwan
Intra-domain communication between the N-terminal and DNA-binding domains of the androgen receptor: modulation of androgen response element DNA binding
J. Mol. Endocrinol., June 1, 2005; 34(3): 603 - 615.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
K. Steketee, A. C J Ziel-van der Made, H. A G M van der Korput, A. B Houtsmuller, and J. Trapman
A bioinformatics-based functional analysis shows that the specifically androgen-regulated gene SARG contains an active direct repeat androgen response element in the first intron
J. Mol. Endocrinol., October 1, 2004; 33(2): 477 - 491.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. Callewaert, G. Verrijdt, A. Haelens, and F. Claessens
Differential Effect of Small Ubiquitin-Like Modifier (SUMO)-ylation of the Androgen Receptor in the Control of Cooperativity on Selective Versus Canonical Response Elements
Mol. Endocrinol., June 1, 2004; 18(6): 1438 - 1449.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Centrella, T. L. McCarthy, W.-Z. Chang, D. C. Labaree, and R. B. Hochberg
Estren (4-Estren-3{alpha},17{beta}-diol) Is a Prohormone that Regulates Both Androgenic and Estrogenic Transcriptional Effects through the Androgen Receptor
Mol. Endocrinol., May 1, 2004; 18(5): 1120 - 1130.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. L. Shaffer, A. Jivan, D. E. Dollins, F. Claessens, and D. T. Gewirth
Structural basis of androgen receptor binding to selective androgen response elements
PNAS, April 6, 2004; 101(14): 4758 - 4763.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society